GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » PT Kalbe Farma Tbk (ISX:KLBF) » Definitions » Equity-to-Asset

PT Kalbe Farma Tbk (ISX:KLBF) Equity-to-Asset : 0.79 (As of Dec. 2023)


View and export this data going back to 1991. Start your Free Trial

What is PT Kalbe Farma Tbk Equity-to-Asset?

Equity to Asset ratio is calculated as total stockholders equity divided by total asset. PT Kalbe Farma Tbk's Total Stockholders Equity for the quarter that ended in Dec. 2023 was Rp21,418,857 Mil. PT Kalbe Farma Tbk's Total Assets for the quarter that ended in Dec. 2023 was Rp27,057,568 Mil. Therefore, PT Kalbe Farma Tbk's Equity to Asset Ratio for the quarter that ended in Dec. 2023 was 0.79.

The historical rank and industry rank for PT Kalbe Farma Tbk's Equity-to-Asset or its related term are showing as below:

ISX:KLBF' s Equity-to-Asset Range Over the Past 10 Years
Min: 0.75   Med: 0.78   Max: 0.81
Current: 0.79

During the past 13 years, the highest Equity to Asset Ratio of PT Kalbe Farma Tbk was 0.81. The lowest was 0.75. And the median was 0.78.

ISX:KLBF's Equity-to-Asset is ranked better than
80.15% of 1088 companies
in the Drug Manufacturers industry
Industry Median: 0.59 vs ISX:KLBF: 0.79

PT Kalbe Farma Tbk Equity-to-Asset Historical Data

The historical data trend for PT Kalbe Farma Tbk's Equity-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PT Kalbe Farma Tbk Equity-to-Asset Chart

PT Kalbe Farma Tbk Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Equity-to-Asset
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.78 0.77 0.76 0.75 0.79

PT Kalbe Farma Tbk Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Equity-to-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.75 0.75 0.73 0.76 0.79

Competitive Comparison of PT Kalbe Farma Tbk's Equity-to-Asset

For the Drug Manufacturers - General subindustry, PT Kalbe Farma Tbk's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


PT Kalbe Farma Tbk's Equity-to-Asset Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, PT Kalbe Farma Tbk's Equity-to-Asset distribution charts can be found below:

* The bar in red indicates where PT Kalbe Farma Tbk's Equity-to-Asset falls into.



PT Kalbe Farma Tbk Equity-to-Asset Calculation

Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.

Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.

PT Kalbe Farma Tbk's Equity to Asset Ratio for the fiscal year that ended in Dec. 2023 is calculated as

Equity to Asset (A: Dec. 2023 )=Total Stockholders Equity/Total Assets
=21418856.503/27057568.182
=0.79

PT Kalbe Farma Tbk's Equity to Asset Ratio for the quarter that ended in Dec. 2023 is calculated as

Equity to Asset (Q: Dec. 2023 )=Total Stockholders Equity/Total Assets
=21418856.503/27057568.182
=0.79

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


PT Kalbe Farma Tbk  (ISX:KLBF) Equity-to-Asset Explanation

Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.

For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.


PT Kalbe Farma Tbk Equity-to-Asset Related Terms

Thank you for viewing the detailed overview of PT Kalbe Farma Tbk's Equity-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.


PT Kalbe Farma Tbk (ISX:KLBF) Business Description

Traded in Other Exchanges
Address
Jalan Let. Jend. Suprapto Kav. 4, Gedung KALBE, Cempaka Putih, Jakarta, IDN, 10510
Kalbe Farma is a drug manufacturing company that focuses on prescription pharmaceuticals, over-the-counter drugs, energy drinks, and nutrition products. The company operates four segments: prescription pharmaceuticals, consumer health, Nutritionals, and distribution and logistics. Majority of the company's gross profits are derived from the distribution and logistics segments. The company primarily operates in Indonesia but has operations across various ASEAN countries, Nigeria, and South Africa.

PT Kalbe Farma Tbk (ISX:KLBF) Headlines

No Headlines